Molecular remission using low-dose immunotherapy for relapsed refractory Philadelphia chromosome-positive precursor B-cell acute lymphoblastic leukemia post-allogeneic stem cell transplant.

Maharaj, Dipnarine; Vianna, Pedro; DeCarvalho, Gabriel; Pourkalbassi, Delaram; Hickey, Christopher; Gouvea, Jacqueline

Maharaj, Dipnarine; Vianna, Pedro; DeCarvalho, Gabriel; Pourkalbassi, Delaram; Hickey, Christopher; Gouvea, Jacqueline.

Afiliación

Maharaj D; The Maharaj Institute of Immune Regenerative Medicine, Boynton Beach, FL 33437, USA.
Vianna P; The Maharaj Institute of Immune Regenerative Medicine, Boynton Beach, FL 33437, USA.
DeCarvalho G; Stanford University Department of Medicine, Stanford, CA 94305, USA.
Pourkalbassi D; Stanford University Department of Medicine, Stanford, CA 94305, USA.
Hickey C; Florida State University College of Medicine, Tallahassee, FL 32306-4300, USA.
Gouvea J; Florida State University College of Medicine, Tallahassee, FL 32306-4300, USA.

Future Sci OA ; 5(5): FSO380, 2019 Jun.

Article en En | MEDLINE | ID: mdl-31245042

Palabras clave

allo-HCT; immunotherapy; natural killer cell; rIL-2; refractory Ph+ ALL

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Future Sci OA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google